Straus, D J <br/><br/>
Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  1983 
 - 80-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/BF00254250  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bleomycin--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Lomustine--administration & dosage<br/>Male<br/>Mechlorethamine--administration & dosage<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Prednisone--administration & dosage<br/>Procarbazine--administration & dosage<br/>Vinblastine--administration & dosage<br/>Vincristine--administration & dosage<br/>Vindesine